Table 1.
Prognostic value of ACC subtype after adjusting for clinicopathological parameters.
| HR | 95% CI | p Value | |
|---|---|---|---|
| TCGA-ACC Cohort | |||
| Age | 1.013 | (0.986–1.041) | 0.351 |
| Gender, male vs. female | 1.455 | (0.614–3.451) | 0.394 |
| Laterality, right vs. left | 1.533 | (0.664–3.54) | 0.317 |
| Stage | |||
| Stage II vs. stage I | 2.883 | (0.301–27.628) | 0.358 |
| Stage III vs. stage I | 6.28 | (0.641–61.55) | 0.115 |
| Stage IV vs. stage I | 16.164 | (1.49–175.301) | 0.022 |
| Stage unknow vs. stage I | 2.451 | (0.117–51.349) | 0.564 |
| ACC subtype | |||
| ACC2 vs. ACC1 | 45.146 | (7.393–275.694) | 0 |
| ACC3 vs. ACC1 | 4.661 | (0.877–24.779) | 0.071 |
| GEO cohort | |||
| Age | 1.01 | (0.99–1.031) | 0.31 |
| Gender, male vs. female | 1.236 | (0.649–2.354) | 0.518 |
| Laterality | |||
| Right vs. left | 1.15 | (0.54–2.45) | 0.717 |
| Unknow vs. left | 1.2 | (0.51–2.822) | 0.677 |
| Stage | |||
| Stage II vs. stage I | 2.765 | (0.351–21.81) | 0.334 |
| Stage III vs. stage I | 8.223 | (0.909–74.351) | 0.061 |
| Stage IV vs. stage I | 11.723 | (1.504–91.399) | 0.019 |
| Stage unknow vs. stage I | 4.067 | (0.453–36.548) | 0.21 |
| ACC subtype | |||
| ACC2 vs. ACC1 | 4.959 | (2.241–10.97) | 0 |
| ACC3 vs. ACC1 | 2.578 | (1.048–6.341) | 0.039 |